For the year ending 2025-10-31, ANIX made $12,273K in revenue. -$10,927K in net income. Net profit margin of -89.03%.
| Income Statement | 2025-10-31 | 2024-10-31 | ||
|---|---|---|---|---|
| Research and development expenses (including non-cash stock-based compensation expenses of 1,560 and 1,859, respectively) | 5,071 | 6,396 | ||
| General and administrative expenses (including non-cash stock-based compensation expenses of 2,250 and 2,923, respectively) | 6,630 | 7,435 | ||
| Total operating costs and expenses | 11,701 | 13,831 | ||
| Loss from operations | -11,701 | -13,831 | ||
| Interest income | 673 | 1,133 | ||
| Net loss | -11,028 | -12,698 | ||
| Less net loss attributable to noncontrolling interest | -101 | -144 | ||
| Net loss attributable to common shareholders | -10,927 | -12,554 | ||
| Basic | -0.34 | -0.39 | ||
| Basic | 32,454 | 31,898 | ||
| Diluted | -0.34 | -0.39 | ||
| Diluted | 32,454 | 31,898 | ||
Anixa Biosciences Inc (ANIX)
Anixa Biosciences Inc (ANIX)